Anúncio
Anúncio

ANRO

ANRO logo

Alto Neuroscience Inc.

15.04
USD
Patrocinado
-1.49
-9.02%
06 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

15.21

+0.17
+1.10%

Relatórios de Lucros ANRO

Rácio de surpresa positiva

ANRO separação 5 de 8 últimas estimativas.

63%

Próximo Relatório

Data do Próximo Relatório
20 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.54
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
+3.85%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
-3.57%

Alto Neuroscience Inc. earnings per share and revenue

On 12 de nov. de 2025, ANRO reported earnings of -0.52 USD per share (EPS) for Q3 25, beating the estimate of -0.68 USD, resulting in a 23.65% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +5.97% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analistas forecast an EPS of -0.54 USD, with revenue projected to reach -- USD, implying an aumentar of 3.85% EPS, and aumentar of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
For Q3 2025, Alto Neuroscience Inc. reported EPS of -$0.52, beating estimates by 23.65%, and revenue of $0.00, 0% as expectations.
The stock price moved up 5.97%, changed from $13.40 before the earnings release to $14.20 the day after.
The next earning report is scheduled for 20 de mar. de 2026.
Based on 12 analistas, Alto Neuroscience Inc. is expected to report EPS of -$0.54 and revenue of -- for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio